Publication:
Phagocytic activity of neutrophils improves over the course of therapy of diabetic foot infections

dc.contributor.authorsTop, Cihan; Yidiz, Senol; Oencuel, Oral; Qydedi, Tauland; Cevikbas, Adile; Soyogul, Urnran Gurer; Cavuslu, Saban
dc.date.accessioned2022-03-12T17:33:12Z
dc.date.accessioned2026-01-11T13:48:41Z
dc.date.available2022-03-12T17:33:12Z
dc.date.issued2007
dc.description.abstractAims: The aim of this study was to investigate changes in phagocytic activity of neutrophils of type 2 diabetic patients with foot infections over short treatment courses. The potential utility of the phagocytic index in determining the efficacy of treatment modalities and it's relationship with metabolic control parameters were evaluated. Methods: The phagocytic activity of neutrophils was determined in blood samples of 38 type 2 diabetic patients with foot infections (14 women and 24 men). Mean age and mean duration of diabetes were 66.3 +/- 9.4 and 19.1 +/- 11.2 (yrs), respectively. All patients received standard treatment (intensive insulin therapy, antibiotherapy, hyperbaric oxygen therapy and surgical debridement). Phagocytic activity of neutrophils was determined by a standard method. Phagocytic activity of neutrophils, acute phase proteins (C-reactive protein) and glycosylated haemoglobin was determined before therapy and two weeks later. Results: The phagocytic index before and after therapy were 47.7 +/- 11.4 and 62.5 +/- 15.6, respectively (p < 0.05). There was a significant correlation between phagocytic index and both CRP and HbA1c (r = 0.52, p < 0.05 and r = -0.41, p < 0.05, respectively). Conclusions: Derangement of carbohydrate metabolism may underlie the impairment of bactericidal activity of neutrophils of poorly controlled diabetic patients. These data reveal that phagocytic activity improves during short-course standard therapy and might enable monitoring of efficacy of treatment modalities in diabetic: patients with foot infections. (C) 2007 The British Infection Society. Published by Elsevier Ltd. All rights reserved.
dc.identifier.doi10.1016/j.jinf.2007.06.003
dc.identifier.issn0163-4453
dc.identifier.pubmed17675245
dc.identifier.urihttps://hdl.handle.net/11424/228793
dc.identifier.wosWOS:000249948300011
dc.language.isoeng
dc.publisherW B SAUNDERS CO LTD
dc.relation.ispartofJOURNAL OF INFECTION
dc.rightsinfo:eu-repo/semantics/closedAccess
dc.subjectneutrophil phagocytic index
dc.subjecttreatment efficacy
dc.subjectdiabetic foot infections
dc.subjectCOLONY-STIMULATING FACTOR
dc.subjectGLUCOSE CONTROL
dc.subjectOXIDATIVE BURST
dc.subjectIN-VITRO
dc.subjectMELLITUS
dc.subjectDYSFUNCTIONS
dc.subjectASSOCIATION
dc.subjectMANAGEMENT
dc.subjectULCERS
dc.titlePhagocytic activity of neutrophils improves over the course of therapy of diabetic foot infections
dc.typearticle
dspace.entity.typePublication
oaire.citation.endPage373
oaire.citation.issue4
oaire.citation.startPage369
oaire.citation.titleJOURNAL OF INFECTION
oaire.citation.volume55

Files